Rg3039 T3336
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
RG3039 (PF-06687859)�is a potent DcpS inhibitor. DcpS is a therapeutic target for spinal muscular atrophy. Spinal muscular atrophy (SMA) is caused by deletion or mutation of both copies of the SMN1 gene which produces an essential protein known as SMN. RG
CAS nr:
1005504-62-0
Purity:
98%
Molecular Weight:
432,35
SMILES:
C1CN(CCC1COc1cccc2c1c(nc(n2)N)N)Cc1c(cccc1Cl)Cl
Formula:
C21H23Cl2N5O
Pathway:
Others
Target:
Others
